Metabolic Syndrome Research Funded

Around the world, an increasing number of people fall ill with complex metabolic disorders. The metabolic syndrome is one of the particularly severe forms of such disorders, characterised by an excess of weight, high blood pressure, abnormal levels of lipids in the blood and insulin resistance. In the context of the portfolio topic "Metabolische Dysfunktion und Volkserkrankungen" (Metabolic Dysfunction and Widespread Diseases), the Helmholtz Association's health centres research the causes and options for diagnosis and treatment in cooperation with university and extramural partners. The portfolio topic is funded with a total of 15 million Euro up until 2016. Epidemiological studies reveal that the metabolic syndrome not only increases the risk of diabetes and cardiovascular diseases, in particular in the case of young people, but that it also can promote the onset of cancer and infection diseases as well as of neuropsychiatric and neurodegenerative diseases.

back